Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology.
George
J N
JN
Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, 73190, USA.
Woolf
S H
SH
Raskob
G E
GE
Wasser
J S
JS
Aledort
L M
LM
Ballem
P J
PJ
Blanchette
V S
VS
Bussel
J B
JB
Cines
D B
DB
Kelton
J G
JG
Lichtin
A E
AE
McMillan
R
R
Okerbloom
J A
JA
Regan
D H
DH
Warrier
I
I
D000328:Adult; D001327:Autoimmune Diseases / Q000628:therapy*; D001856:Bone Marrow Examination; D002648:Child; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004630:Emergencies; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006470:Hemorrhage / Q000209:etiology / Q000517:prevention & control; D006760:Hospitalization; D006801:Humans; D007112:Immunity, Maternally-Acquired; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007231:Infant, Newborn; D008297:Male; D010976:Platelet Count; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000175:diagnosis / Q000628:therapy; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000150:complications / Q000151:congenital / Q000175:diagnosis / Q000628:therapy*; D018029:Rho(D) Immune Globulin / Q000627:therapeutic use; D013156:Splenectomy; D016896:Treatment Outcome
D005938:Glucocorticoids; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D018029:Rho(D) Immune Globulin